Search

everythinglearnresearchcommunity

for

Search:↓

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

A new MBTPS2 gene variant disrupts fat metabolism and collagen production, causing Osteogenesis imperfecta.

Apremilast shows promise for several skin conditions but needs more research.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Dermatopathology has made significant progress but many skin diseases remain incurable, requiring ongoing research.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

The document is a detailed medical reference on skin and genetic disorders.

Newspaper articles on alopecia are often inaccurate and sometimes mix up different types of hair loss.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

The 2017 issue emphasized progress in laser and energy-based skin treatments, but noted the need for more research on certain procedures and technologies.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

Understanding hair structure and growth is key for diagnosing hair diseases accurately.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Psoriasis treatments range from topical creams to systemic medications with serious side effects, and while treatments can manage symptoms, there is no cure.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.